Pentexifylline modulates deformability, F-actin content, and superoxide anion production of polymorphonuclear leukocytes from diabetic cats

Experimental Eye Research

Volumn 55, Issue 6, 1992, Pages 831-838

  Sonkin, Peter L ^a   Freedman, Sharon F ^a   Needham, David ^a   Rao, K Murali K ^b   Hatchell, Diane L ^a,b  

^a DUKE UNIVERSITY   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

capillary occulsion; deformability, F actin; diabetic cat; pentoxifylline; polymorphonuclear leukocyte; retinopathy; superoxide anion

Indexed keywords

F ACTIN; PENTOXIFYLLINE; SUPEROXIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY FLOW; CASE REPORT; CAT; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ACTINS; ANIMAL; ANIONS; CATS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; NEUTROPHILS; PENTOXIFYLLINE; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027104199     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-4835(92)90009-H     Document Type: Article

References (45)

1. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease
2. Effect of pentoxifylline on the flow of polymorphonuclear leukocytes through a model capillary
3. Pentoxifylline. A new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects
4. Evaluation of neutrophil activity and circulating immune complexes levels in diabetic patients
5. Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock
6. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells
7. Superoxide generation by digitonin-stimulated guinea pig granulocytes
8. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production
9. Polymorphonuclear (PMN) filterability in diabetes mellitus
10. Appendix 1
11. Improvement of the flow properties of blood. A new therapeutical approach in occlusive arterial disease
12. Effects of orally administered pentoxifylline on muscular oxygen pressure in patients with intermittent claudication
13. Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque
14. Altered red and white blood cell rheology in type II diabetes
15. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients
16. Time-dependent alterations in the deformability of human neutrophils in response to chemotactic activation
17. Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes
18. Effects compares sur la filtrabilite in vivo chez l'homme de deux formes galeniques de la pentoxifylline
19. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor
20. Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes
21. A controlled study on the efficacy of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease
22. Preventive treatment of cerebral transient ischemia: Comparative randomized trial of pentoxifylline versus conventional antiaggregants
23. Efficacy of pentoxifylline in patients with stable angina pectoris
24. Retinal Ischemia
25. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline
26. Pentoxifylline improves white cell rheology in claudicants
27. Rapiddeformationof“passive”polymorphonuclear leukocytes: the effects of pentoxifylline
28. Role of different blood cell types in blood rheology
29. Activation and decreased deformability of neutrophils after intermittent claudication
30. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients
31. Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils
32. Experimental diabetes in cats: induced by partial pancreatectomy alone or combined with local injection of Alloxan
33. On the assessment of the efficacy of pentoxifylline (Trental)
34. Filterability of leukocytes: effect of pentoxifylline
35. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy
36. Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders
37. The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane
38. 2 of human brain cortex—method, basic results and effects of pentoxifylline
39. Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients
40. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients
41. Macular retinal capillary hemodynamics in diabetic patients
42. Influence of physicochemical factors on rheology of human neutrophils
43. Rheological properties of white blood cells are changed in diabetic patients with microvascular disease
44. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
45. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus